See more : Kuwait Finance House K.S.C.P. (KFH.KW) Income Statement Analysis – Financial Results
Complete financial analysis of Halma plc (HLMAF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Halma plc, a leading company in the Conglomerates industry within the Industrials sector.
You may be interested
- Full House Resorts, Inc. (FLL) Income Statement Analysis – Financial Results
- Swelect Energy Systems Limited (SWELECTES.NS) Income Statement Analysis – Financial Results
- HOV Services Limited (HOVS.BO) Income Statement Analysis – Financial Results
- Rimfire Pacific Mining Limited (RIM.AX) Income Statement Analysis – Financial Results
- Digizuite A/S (DIGIZ.CO) Income Statement Analysis – Financial Results
Halma plc (HLMAF)
About Halma plc
Halma plc, through its subsidiaries, provides technology solutions in the safety, health, and environmental markets. It operates through three segments: Safety, Environmental & Analysis, and Medical. The Safety segment provides fire detection, specialist fire suppression, elevator safety, security sensors, people and vehicle flow technologies, specialized interlocks that control critical processes safely, and explosion protection and corrosion monitoring systems. This segment serves elevator safety, fire suppression, people and vehicle flow, fire detection, pressure management, industrial access control, and safe storage and transfer markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; water, air and gases monitoring technologies; instruments that detect hazardous gases and analyses air quality; and systems for water analysis and treatment. It serves the optical analysis, water analysis and treatment, gas detection, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and original equipment manufacturers; laboratory devices and systems that provide information to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable positive outcomes across clinical specialties. This segment serves the life sciences, health assessment, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.03B | 1.85B | 1.53B | 1.32B | 1.34B | 1.21B | 1.08B | 961.66M | 807.81M | 726.13M | 676.51M | 619.21M | 579.88M | 518.43M | 459.12M | 455.93M | 395.06M | 351.12M | 310.77M | 268.72M | 292.64M | 267.29M | 267.60M | 268.32M | 233.49M | 217.76M | 213.78M | 200.14M | 173.65M | 153.74M | 135.32M | 116.15M | 94.55M | 81.87M | 78.08M | 61.10M | 50.82M | 36.86M | 31.15M |
| Cost of Revenue | 1.03B | 974.90M | 801.00M | 704.60M | 707.10M | 644.80M | 540.67M | 482.82M | 408.97M | 342.87M | 321.99M | 297.70M | 285.01M | 345.84M | 310.53M | 313.84M | 266.58M | 236.58M | 207.44M | 208.06M | 205.12M | 187.01M | 189.02M | 187.97M | 163.50M | 152.13M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.00B | 877.90M | 724.30M | 613.60M | 631.30M | 566.10M | 535.54M | 478.84M | 398.83M | 383.26M | 354.52M | 321.51M | 294.88M | 172.59M | 148.59M | 142.09M | 128.48M | 114.54M | 103.33M | 60.66M | 87.52M | 80.29M | 78.57M | 80.35M | 69.99M | 65.63M | 213.78M | 200.14M | 173.65M | 153.74M | 135.32M | 116.15M | 94.55M | 81.87M | 78.08M | 61.10M | 50.82M | 36.86M | 31.15M |
| Gross Profit Ratio | 49.35% | 47.38% | 47.49% | 46.55% | 47.17% | 46.75% | 49.76% | 49.79% | 49.37% | 52.78% | 52.40% | 51.92% | 50.85% | 33.29% | 32.36% | 31.16% | 32.52% | 32.62% | 33.25% | 22.57% | 29.91% | 30.04% | 29.36% | 29.94% | 29.98% | 30.14% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 71.20M | 58.60M | 39.50M | 42.60M | 41.10M | 37.65M | 29.12M | 24.07M | 35.43M | 32.31M | 30.36M | 22.71M | 20.95M | 18.30M | 19.06M | 14.84M | 11.42M | 10.95M | 11.76M | 11.24M | 9.62M | 8.21M | 7.99M | 6.75M | 6.42M | 6.03M | 5.62M | 4.57M | 4.29M | 3.68M | 3.16M | 2.78M | 2.25M | 1.94M | 1.27M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 415.40M | 404.40M | 316.70M | 267.90M | 270.10M | 231.50M | 222.60M | 189.58M | 154.08M | 131.54M | 108.12M | 113.17M | 101.09M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 30.02M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 220.70M | 210.10M | 168.00M | 144.60M | 162.00M | 149.70M | 162.90M | 153.66M | 124.91M | 114.66M | 102.83M | 91.04M | 83.88M | 11.07M | 9.62M | 10.73M | 9.12M | 8.45M | 7.07M | 6.33M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 636.10M | 485.20M | 380.90M | 321.80M | 343.10M | 306.70M | 306.73M | 277.25M | 225.99M | 246.20M | 210.95M | 204.21M | 184.97M | 11.07M | 9.62M | 10.73M | 9.12M | 8.45M | 7.07M | 36.34M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.55M | -2.01M | -1.42M | -1.88M | -470.00K | 0.00 | 0.00 | -2.00M | -759.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -7.77M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.14M | 14.08M | 11.41M | 8.92M | 6.39M | 5.22M |
| Operating Expenses | 636.10M | 556.40M | 439.50M | 361.30M | 385.70M | 347.80M | 344.38M | 306.37M | 250.06M | 246.20M | 210.95M | 204.21M | 184.97M | 73.54M | 64.77M | 66.31M | 59.58M | 50.88M | 44.69M | 11.67M | 27.83M | 34.41M | 30.51M | 30.56M | 18.79M | 24.79M | 166.37M | 163.15M | 140.46M | 124.82M | 110.21M | 95.72M | 77.50M | 81.87M | 78.08M | 61.10M | 50.82M | 36.86M | 31.15M |
| Cost & Expenses | 1.67B | 1.53B | 1.24B | 1.07B | 1.09B | 992.60M | 885.05M | 789.19M | 659.03M | 589.07M | 532.94M | 501.91M | 469.97M | 419.38M | 375.30M | 380.15M | 326.16M | 287.45M | 252.13M | 219.73M | 232.95M | 221.41M | 219.53M | 218.53M | 182.29M | 176.92M | 166.37M | 163.15M | 140.46M | 124.82M | 110.21M | 95.72M | 77.50M | 81.87M | 78.08M | 61.10M | 50.82M | 36.86M | 31.15M |
| Interest Income | 3.10M | 700.00K | 200.00K | 800.00K | 600.00K | 400.00K | 255.00K | 211.00K | 217.00K | 134.00K | 252.00K | 195.00K | 9.74M | 317.00K | 189.00K | 643.00K | 721.00K | 1.04M | 1.03M | 5.66M | 995.00K | 1.22M | 820.00K | 708.00K | 1.09M | 1.62M | 1.00M | 845.00K | 1.09M | 874.00K | 719.00K | 1.36M | 1.06M | 1.10M | 929.00K | 222.00K | 319.00K | 213.00K | 247.00K |
| Interest Expense | 29.60M | 18.30M | 8.70M | 10.80M | 11.70M | 9.00M | 8.15M | 8.14M | 4.71M | 4.58M | 4.74M | 4.06M | 11.23M | 1.25M | 3.05M | 4.06M | 2.87M | 2.86M | 2.85M | 6.72M | 763.00K | 812.00K | 583.00K | 713.00K | 754.00K | 573.00K | 420.00K | 496.00K | 583.00K | 480.00K | 607.00K | 791.00K | 939.00K | 988.00K | 871.00K | 271.00K | 158.00K | 139.00K | 190.00K |
| Depreciation & Amortization | 105.60M | 101.50M | 88.60M | 90.30M | 84.70M | 66.20M | 62.31M | 57.65M | 44.90M | 40.68M | 36.31M | 31.90M | 27.67M | 21.73M | 21.23M | 20.34M | 15.88M | 13.13M | 11.34M | 9.32M | 7.88M | 7.55M | 7.37M | 7.02M | 6.25M | 5.75M | 5.33M | 4.99M | 4.40M | 4.01M | 3.53M | 2.96M | 2.51M | 2.23M | 1.80M | 1.44M | 1.13M | 935.00K | 756.00K |
| EBITDA | 475.50M | 410.60M | 373.40M | 342.60M | 320.60M | 282.30M | 243.20M | 224.04M | 187.39M | 178.87M | 179.73M | 148.41M | 150.87M | 121.27M | 105.36M | 97.19M | 85.58M | 78.15M | 70.83M | 63.99M | 59.04M | 51.64M | 53.91M | 55.50M | 50.77M | 47.87M | 47.97M | 42.57M | 38.60M | 33.72M | 29.21M | 24.64M | 17.67M | 16.47M | 16.81M | 13.07M | 10.37M | 7.54M | 6.22M |
| EBITDA Ratio | 23.38% | 22.83% | 24.48% | 25.99% | 24.68% | 23.49% | 23.55% | 23.93% | 23.98% | 24.43% | 26.58% | 23.97% | 25.35% | 23.40% | 22.95% | 21.24% | 21.66% | 22.17% | 22.85% | 23.81% | 20.17% | 20.47% | 21.02% | 21.44% | 21.74% | 22.14% | 22.44% | 21.40% | 22.28% | 21.99% | 21.70% | 21.30% | 20.33% | 20.12% | 21.52% | 21.39% | 20.40% | 20.45% | 19.98% |
| Operating Income | 367.70M | 321.50M | 284.80M | 252.30M | 245.60M | 218.30M | 191.16M | 172.47M | 148.78M | 137.06M | 143.57M | 117.30M | 109.91M | 99.45M | 84.30M | 76.21M | 70.17M | 63.98M | 58.46M | 49.02M | 46.21M | 42.80M | 45.72M | 47.77M | 42.14M | 40.50M | 41.81M | 36.73M | 33.11M | 28.84M | 24.96M | 20.33M | 15.50M | 14.24M | 15.01M | 11.63M | 9.24M | 6.60M | 5.47M |
| Operating Income Ratio | 18.08% | 17.35% | 18.67% | 19.14% | 18.35% | 18.03% | 17.76% | 17.93% | 18.42% | 18.88% | 21.22% | 18.94% | 18.95% | 19.18% | 18.36% | 16.71% | 17.76% | 18.22% | 18.81% | 18.24% | 15.79% | 16.01% | 17.09% | 17.80% | 18.05% | 18.60% | 19.56% | 18.35% | 19.07% | 18.76% | 18.45% | 17.50% | 16.39% | 17.40% | 19.22% | 19.04% | 18.18% | 17.91% | 17.55% |
| Total Other Income/Expenses | -27.40M | -30.00M | 25.60M | 600.00K | -16.00M | -11.10M | -15.30M | -9.37M | -11.82M | -3.45M | -4.89M | 2.12M | 2.06M | -1.16M | -2.92M | -3.42M | -2.14M | -1.83M | -1.82M | -1.05M | -9.30M | 474.00K | 237.00K | -5.00K | -7.44M | 1.05M | -5.18M | 349.00K | 509.00K | 394.00K | 112.00K | 565.00K | -1.28M | -988.00K | -871.00K | -271.00K | -158.00K | -139.00K | -190.00K |
| Income Before Tax | 340.30M | 291.50M | 304.50M | 252.90M | 224.20M | 206.80M | 172.26M | 157.78M | 136.45M | 133.61M | 138.68M | 120.14M | 111.97M | 98.29M | 81.37M | 72.79M | 68.02M | 62.15M | 56.64M | 47.96M | 36.92M | 43.27M | 45.96M | 47.76M | 34.70M | 41.55M | 36.63M | 37.08M | 33.62M | 29.23M | 25.08M | 20.89M | 14.22M | 13.26M | 14.14M | 11.36M | 9.08M | 6.46M | 5.28M |
| Income Before Tax Ratio | 16.73% | 15.73% | 19.96% | 19.19% | 16.75% | 17.08% | 16.01% | 16.41% | 16.89% | 18.40% | 20.50% | 19.40% | 19.31% | 18.96% | 17.72% | 15.96% | 17.22% | 17.70% | 18.23% | 17.85% | 12.61% | 16.19% | 17.17% | 17.80% | 14.86% | 19.08% | 17.13% | 18.53% | 19.36% | 19.02% | 18.53% | 17.99% | 15.04% | 16.19% | 18.10% | 18.60% | 17.87% | 17.54% | 16.94% |
| Income Tax Expense | 71.50M | 57.20M | 60.20M | 49.60M | 39.70M | 36.90M | 17.72M | 28.01M | 27.45M | 29.61M | 32.35M | 26.53M | 25.26M | 25.86M | 20.94M | 20.21M | 19.69M | 18.45M | 17.03M | 14.47M | 14.59M | 14.91M | 14.80M | 15.64M | 12.69M | 12.96M | 11.85M | 11.97M | 10.69M | 9.42M | 8.29M | 6.47M | 4.55M | 4.09M | 4.56M | 3.73M | 3.24M | 2.28M | 1.93M |
| Net Income | 268.80M | 234.50M | 244.40M | 203.40M | 184.40M | 169.80M | 154.20M | 129.69M | 108.84M | 104.00M | 106.33M | 93.61M | 86.71M | 72.43M | 60.44M | 52.58M | 50.28M | 44.01M | 40.88M | 34.55M | 22.32M | 28.36M | 31.16M | 32.12M | 22.01M | 28.59M | 24.78M | 25.10M | 22.93M | 19.81M | 16.79M | 14.40M | 9.67M | 8.08M | 10.43M | 7.93M | 5.84M | 3.69M | 3.33M |
| Net Income Ratio | 13.21% | 12.66% | 16.02% | 15.43% | 13.78% | 14.02% | 14.33% | 13.49% | 13.47% | 14.32% | 15.72% | 15.12% | 14.95% | 13.97% | 13.16% | 11.53% | 12.73% | 12.53% | 13.15% | 12.86% | 7.63% | 10.61% | 11.64% | 11.97% | 9.43% | 13.13% | 11.59% | 12.54% | 13.20% | 12.89% | 12.41% | 12.40% | 10.23% | 9.87% | 13.35% | 12.97% | 11.50% | 10.00% | 10.68% |
| EPS | 0.71 | 0.62 | 0.65 | 0.54 | 0.49 | 0.45 | 0.41 | 0.34 | 0.29 | 0.27 | 0.28 | 0.25 | 0.23 | 0.19 | 0.16 | 0.14 | 0.13 | 0.12 | 0.11 | 0.09 | 0.06 | 0.08 | 0.09 | 0.09 | 0.06 | 0.08 | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 | 0.04 | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 |
| EPS Diluted | 0.71 | 0.62 | 0.64 | 0.54 | 0.49 | 0.45 | 0.41 | 0.34 | 0.29 | 0.27 | 0.28 | 0.25 | 0.23 | 0.19 | 0.16 | 0.14 | 0.13 | 0.12 | 0.11 | 0.09 | 0.06 | 0.08 | 0.09 | 0.09 | 0.06 | 0.08 | 0.07 | 0.07 | 0.06 | 0.06 | 0.05 | 0.04 | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.01 | 0.01 |
| Weighted Avg Shares Out | 377.30M | 378.00M | 378.70M | 379.16M | 379.09M | 379.16M | 378.99M | 378.69M | 378.41M | 378.33M | 377.81M | 377.60M | 376.93M | 376.61M | 375.49M | 373.83M | 372.77M | 371.22M | 369.05M | 368.18M | 366.24M | 365.41M | 363.10M | 360.65M | 361.34M | 360.97M | 359.99M | 357.51M | 355.86M | 354.07M | 349.56M | 342.92M | 329.82M | 317.50M | 309.45M | 297.83M | 240.59M | 271.71M | 260.41M |
| Weighted Avg Shares Out (Dil) | 378.70M | 379.10M | 379.40M | 379.16M | 379.09M | 379.16M | 378.99M | 378.69M | 378.41M | 378.48M | 378.04M | 378.01M | 377.47M | 377.37M | 376.51M | 374.89M | 374.60M | 374.04M | 370.44M | 368.70M | 366.24M | 365.92M | 364.84M | 361.10M | 362.20M | 362.26M | 361.43M | 357.51M | 355.86M | 354.07M | 349.56M | 342.92M | 329.82M | 317.50M | 309.45M | 297.83M | 240.59M | 271.71M | 260.41M |
ECB rate decision and Halma results on Thursday
Thursday offers up some of London's less glamorous stocks, including health and safety specialist Halma PLC (LSE:HLMA), shower trays maker Norcros and Bunzl PLC (LSE:BNZL), a distributor of packaging, hygiene and personal protection equipment. For FTSE 100-listed Halma, this will be the first...
Barclays suggests 10 'compounders' for long-term investors
Investors should consider "compounders" that might not necessarily be operating in especially interesting or high-growth end markets, said Barclays, identifying several companies among the UK mid- and small-cap scene, including Greggs, Halma and 4imprint Group. "As a team, we are regularly asked by...
Halma: Smart M&A Policy But Still Not Cheap
Halma is a UK-based holding company, owning and operating close to 50 companies. The share price is down by almost 30% since my previous article, but that doesn't make the company cheap.
Sell Halma buy Spirax, says UBS
Halma PLC (LSE:HLMA) is likely to need to make larger acquisitions in order to meet its 10% earnings growth targets, which is too risky a prospect for UBS, which has taken the shares off its ‘buy' list. Instead, the Swiss...
Halma plc (HLMAF) H1 2022/23 Earnings Call Transcript
Halma plc (OTCPK:HLMAF) H1 2022/23 Earnings Conference Call November 17, 2022 3:30 AM ET Company Participants Andrew Williams - Group Chief Executive Marc Ronchetti - Chief Financial Officer and Group Chief Executive Designate Conference Call Participants Scott Cagehin - Investec...
Halma: Opportunity To Invest As M&A Activity Returns
Halma's September 2022 trading statement was positive, and M&A activity restarted in October 2022. During times of economic uncertainty, investors can find Halma shares valued without a high premium.
Halma plc (HLMAF) CEO Andrew Williams on Q4 2022 Results - Earnings Call Transcript
Halma plc (OTCPK:HLMAF) Q4 2022 Earnings Conference Call June 16, 2022 3:30 AM ET Company Participants Andrew Williams - CEO Marc Ronchetti - CFO Conference Call Participants Mark Jones - Stifel Operator Good morning, everyone, and welcome to our results...
BooHoo and Halma is spotlight for Thursday
Online fast-fashion retailer Boohoo Group PLC (AIM:BOO) and health and safety technology specialist Halma PLC (LSE:HLMA) are among the highlight names in the diary for Thursday. A near 80% drop in its share price over the past year tells you...
Are You Looking For A Stock To Pass On To Your Heirs? Consider Halma PLC
Halma plc is a lesser-known U.K.-based manufacturer of a variety of life-saving and security-related devices and products. Halma's resilient business model and management's impeccable track record in mergers and acquisitions form the basis for its strong profitability.
Halma plc (HLMAF) CEO Andrew Williams on Q2 2022 Results - Earnings Call Transcript
Halma plc (HLMAF) CEO Andrew Williams on Q2 2022 Results - Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports